You have 9 free searches left this month | for more free features.

bimatoprost

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Scars, Hypopigmented Scar, Hypopigmented Skin Trial in Washington (Bimatoprost, Saline)

Recruiting
  • Scars
  • +8 more
  • Washington, District of Columbia
    MedStar Washington Hospital Center
Nov 2, 2023

Vitiligo Trial in Charleston (Bimatoprost, Excimer laser, Microneedling with a dermaroller)

Completed
  • Vitiligo
  • Bimatoprost
  • +2 more
  • Charleston, South Carolina
    Medical University of South Carolina
Aug 3, 2022

Glaucoma Trial in Miami (Latanoprost, Bimatoprost, Travoprost)

Active, not recruiting
  • Glaucoma
  • Miami, Florida
    Bascom Palmer Eye Institute - University of Miami
Oct 7, 2021

Ocular Hypertension, Glaucoma Trial in Tallinn (Bimatoprost, LumiganĀ®)

Completed
  • Ocular Hypertension
  • Glaucoma
  • Tallinn, Estonia
    Hospital
Jul 27, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost
  • +3 more
  • Fayetteville, Arkansas
  • +9 more
May 18, 2020

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost
  • Fayetteville, Arkansas
  • +8 more
Mar 26, 2019

Open-Angle Glaucoma, Ocular Hypertension Trial in Panama City (Fixed Combination, Bimatoprost, Timolol)

Completed
  • Open-Angle Glaucoma
  • Ocular Hypertension
  • Fixed Combination
  • +4 more
  • Panama City, Panama
    Clinica de Ojos Orillac - Calvo
Feb 7, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost
  • Artesia, California
  • +9 more
Feb 1, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Bimatoprost
  • +3 more
  • Artesia, California
  • +9 more
Mar 22, 2018

Alopecia, Alopecia, Androgenetic, Baldness Trial in Austin, College Station, Lynchburg (Bimatoprost)

Terminated
  • Alopecia
  • +2 more
  • Bimatoprost
  • Austin, Texas
  • +2 more
Mar 15, 2017

Graves' Ophthalmopathy Trial in Cardiff (Bimatoprost, Eye drop solution)

Completed
  • Graves' Ophthalmopathy
  • Bimatoprost
  • Eye drop solution
  • Cardiff, United Kingdom
    University Hospital of Wales
May 5, 2016

Glaucoma, Application Site Pigmentation Changes Trial in Arlington Heights, Akron (latanoprost, bimatoprost, travoprost)

Completed
  • Glaucoma
  • Application Site Pigmentation Changes
  • Arlington Heights, Illinois
  • +1 more
Dec 14, 2015

Male Pattern Hair Loss, Androgenetic Alopecia Trial (Bimatoprost, Placebo)

Completed
  • Male Pattern Hair Loss
  • Androgenetic Alopecia
  • Bimatoprost
  • Placebo
  • (no location specified)
Aug 27, 2014

s to Bimatoprost in Primary Open Angle Glaucoma or Ocular

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Bimatoprost
  • Dresden, Germany
  • +1 more
May 15, 2014

Glaucoma Trial in Worldwide (Bimatoprost, Latanoprost/Timolol)

Completed
  • Glaucoma
  • Dresden, Germany
  • +8 more
May 29, 2014

Glaucoma, Open-Angle, Ocular Hypertension Trial in Austin (AGN-210669, bimatoprost, bimatoprost vehicle)

Completed
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Austin, Texas
    (unnamed)
Nov 4, 2013

Ocular Hypertension Trial in Parma (0.5% timolol, timolol-dorzolamide fixed combination, Latanoprost)

Completed
  • Ocular Hypertension
  • 0.5% timolol
  • +4 more
  • Parma, Italy
    University Eye Clinic
Aug 1, 2012

Ocular Hypertension Trial in Newport Beach (bimatoprost)

Completed
  • Ocular Hypertension
  • bimatoprost
  • Newport Beach, California
    (unnamed)
May 27, 2011

Glaucoma Trial in Pittsburgh (Bimatoprost)

Completed
  • Glaucoma
  • Bimatoprost
  • Pittsburgh, Pennsylvania
    Dr. Noecker
May 30, 2007